Clinical Trials Directory

Trials / Completed

CompletedNCT05584943

Kinetics of cEVs Over the 24-hour Dosing Interval After Low-dose Aspirin Administration

Kinetics of Circulating Extracellular Vesicles Over the 24-hour Dosing Interval After Low-dose Aspirin Administration in Patients at Cardiovascular Risk

Status
Completed
Phase
Study type
Observational
Enrollment
93 (actual)
Sponsor
G. d'Annunzio University · Academic / Other
Sex
All
Age
Healthy volunteers
Accepted

Summary

Extracellular vesicles (EVs) are small vesicles deriving from all cell types during cell activation, involved in transcellular communication, and regarded as predictors of vascular damage and of cardiovascular events. The investigators will test the hypothesis that, in patients on chronic low-dose aspirin treatment for cardiovascular prevention, aspirin may affect the release of EVs within the 24 hours interval.

Conditions

Timeline

Start date
2015-09-21
Primary completion
2017-05-09
Completion
2017-12-31
First posted
2022-10-18
Last updated
2022-10-18

Source: ClinicalTrials.gov record NCT05584943. Inclusion in this directory is not an endorsement.